Ming‐Yen Hsieh
- Hepatology top 0.5%
- Hepatitis C virus research 92
- Liver Disease and Transplantation 14
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 89
- Hepatitis B Virus Studies 65
-
- Diabetes Treatment and Management 3
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research 9
- Infectious Diseases top 10%
-
- Chronic Lymphocytic Leukemia Research 3
Ming‐Yen Hsieh
111 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 95
- Hepatology 1.8k
- Epidemiology 1.8k
- Endocrinology, Diabetes and Metabolism 190
- Rheumatology 159
- Infectious Diseases 116
Countries citing papers authored by Ming‐Yen Hsieh
This map shows the geographic impact of Ming‐Yen Hsieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Yen Hsieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Yen Hsieh more than expected).
Fields of papers citing papers by Ming‐Yen Hsieh
This network shows the impact of papers produced by Ming‐Yen Hsieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Yen Hsieh. The network helps show where Ming‐Yen Hsieh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming‐Yen Hsieh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 1 | |
| 13 | 2019 | 6 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 8 | |
| 16 | 2016 | 26 | |
| 17 | 2016 | 9 | |
| 18 | 2013 | 54 | |
| 19 | 2008 | 37 | |
| 20 | 2007 | 22 |
About Ming‐Yen Hsieh
Ming‐Yen Hsieh is a scholar working on Hepatology, Epidemiology and Rheumatology, having authored 112 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (92 papers), Liver Disease Diagnosis and Treatment (89 papers), Hepatitis B Virus Studies (65 papers), Liver Disease and Transplantation (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Systemic Lupus Erythematosus Research (9 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.8k citations) and Endocrinology, Diabetes and Metabolism (190 citations). Ming‐Yen Hsieh has collaborated with scholars based in Taiwan, United States and Mongolia. Frequent co-authors include Wan‐Long Chuang, Chia‐Yen Dai, Ming‐Lung Yu, Jee‐Fu Huang, Zu‐Yau Lin, Liang‐Yen Wang, Ming‐Yuh Hsieh, Shinn‐Cherng Chen, Chung‐Feng Huang and Nai‐Jen Hou. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Hepatology International, PLoS ONE, Journal of Hepatology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.